IL56304A - 3-aminoalkyl)-5-aryl-thiazolidine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

3-aminoalkyl)-5-aryl-thiazolidine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL56304A
IL56304A IL56304A IL5630478A IL56304A IL 56304 A IL56304 A IL 56304A IL 56304 A IL56304 A IL 56304A IL 5630478 A IL5630478 A IL 5630478A IL 56304 A IL56304 A IL 56304A
Authority
IL
Israel
Prior art keywords
thiazolidine
aminoalkyl
aryl
preparation
pharmaceutical compositions
Prior art date
Application number
IL56304A
Other languages
English (en)
Other versions
IL56304A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7739559A external-priority patent/FR2413381A1/fr
Priority claimed from FR7833244A external-priority patent/FR2442232A2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL56304A0 publication Critical patent/IL56304A0/xx
Publication of IL56304A publication Critical patent/IL56304A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL56304A 1977-12-29 1978-12-26 3-aminoalkyl)-5-aryl-thiazolidine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them IL56304A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7739559A FR2413381A1 (fr) 1977-12-29 1977-12-29 Derives de thiazolidinedione et leur application en therapeutique
FR7833244A FR2442232A2 (fr) 1978-11-24 1978-11-24 Derives de thiazolidinedione-2,4 et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IL56304A0 IL56304A0 (en) 1979-03-12
IL56304A true IL56304A (en) 1982-02-28

Family

ID=26220372

Family Applications (1)

Application Number Title Priority Date Filing Date
IL56304A IL56304A (en) 1977-12-29 1978-12-26 3-aminoalkyl)-5-aryl-thiazolidine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US4349683A (xx)
EP (1) EP0002978B1 (xx)
JP (1) JPS6011908B2 (xx)
AR (1) AR223160A1 (xx)
AT (1) AT370098B (xx)
AU (1) AU517221B2 (xx)
CA (1) CA1107740A (xx)
DE (1) DE2862059D1 (xx)
DK (1) DK149429C (xx)
ES (1) ES476408A1 (xx)
FI (1) FI68819C (xx)
GR (1) GR65312B (xx)
IE (1) IE47902B1 (xx)
IL (1) IL56304A (xx)
NO (1) NO148454C (xx)
NZ (1) NZ189300A (xx)
PT (1) PT68991A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPH0750560B2 (ja) * 1981-05-09 1995-05-31 ヤマハ株式会社 ディジタル集積回路装置
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
EP0715853A1 (en) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Use of glutathione esters for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
KR20150068829A (ko) * 2013-12-12 2015-06-22 삼성전자주식회사 알킬 암모늄염 화합물을 포함하는 유도 용질

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1435004A (fr) * 1965-02-04 1966-04-15 Sobio Lab Dérivés de thiazolidine-dione-2, 4- et procédé de préparation

Also Published As

Publication number Publication date
IL56304A0 (en) 1979-03-12
JPS6011908B2 (ja) 1985-03-28
IE47902B1 (en) 1984-07-25
AR223160A1 (es) 1981-07-31
FI68819C (fi) 1985-11-11
AT370098B (de) 1983-02-25
EP0002978A2 (fr) 1979-07-11
NO148454B (no) 1983-07-04
NO784382L (no) 1979-07-02
FI68819B (fi) 1985-07-31
PT68991A (fr) 1979-01-01
DK149429C (da) 1987-03-09
NO148454C (no) 1983-10-12
ATA936678A (de) 1982-07-15
DK149429B (da) 1986-06-09
US4349683A (en) 1982-09-14
AU4296178A (en) 1979-07-05
AU517221B2 (en) 1981-07-16
GR65312B (en) 1980-08-02
IE782561L (en) 1979-06-29
DE2862059D1 (en) 1982-11-11
DK582578A (da) 1979-06-30
JPS5498758A (en) 1979-08-03
FI783995A (fi) 1979-06-30
EP0002978A3 (en) 1979-07-25
CA1107740A (en) 1981-08-25
ES476408A1 (es) 1979-04-01
NZ189300A (en) 1980-05-27
EP0002978B1 (fr) 1982-10-06

Similar Documents

Publication Publication Date Title
IL54842A (en) 1-piperidino-phthalazine derivatives,their preparation and pharmaceutical compositions containing them
IL55465A (en) 2-alkyl-4-hydroxy-n-heteroaryl-2h-thieno(1,2)-thiazine-3-carboxamide 1,1-dioxide derivatives,their preparation and pharmaceutical compositions containing them
IL55557A0 (en) New imidazole derivatives,their preparation and pharmaceutical compositions containing them
IL56155A (en) Substituted alkanoylanilide derivatives,their preparation and pharmaceutical compositions comprising them
IL53996A0 (en) Novel imidazole derivatives, their preparation and pharmaceutical compositions containing them
IL55845A (en) Quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL56284A (en) 7-(2-thiazolyl-2-alkoxyiminoacetamido)-cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
IL55765A (en) Dehydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL54535A0 (en) Novel -lactam derivatives, their preparation and pharmaceutical compositions containing them
IL53857A0 (en) New aminoalkoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL56304A (en) 3-aminoalkyl)-5-aryl-thiazolidine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
IL55894A (en) 1-alkylenedithia (or oxathia) benzyl-4-heteroaryl-piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL55858A (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
IL54547A0 (en) Novel pyridazinone derivatives, their preparation and pharmaceutical compositions containing them
IL53766A0 (en) 4-diphenylmethylene-1-hydroxybenzyl-piperidine derivatives, their preparation and pharmaceutical compositions containing them
IL55857A (en) Benzodioxanylcarbonyl-piperazinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL53861A0 (en) Novel n-aralkylaniline derivatives, their preparation and pharmaceutical compositions containing them
IL53995A (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
IL54819A (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
IL54326A0 (en) Novel quinazoline derivatives, their preparation and pharmaceutical compositions containing them
GB2010261B (en) Phenoxyalkanolamine derivatives the preparation thereof and pharmaceutical compositions containing them
IL54677A (en) N1-carboxylic acyl-n2-phenyl-2-hydroxy-1,3-diaminopropane derivatives, their preparation and pharmaceutical compositions containing them
IL55095A0 (en) Novel piperidino-propanol derivatives,their preparation and pharmaceutical compositions containing them
IL55120A0 (en) New 3-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL55088A0 (en) Novel benzamidine derivatives, their preparation and pharmaceutical compositions containing them